Match!
Yasunori Suematsu
Fukuoka University
EndocrinologyCardiologyCoronary artery diseaseDiabetes mellitusMedicine
62Publications
10H-index
299Citations
What is this?
Publications 62
Newest
#1Kota Motozato (Fukuoka University)H-Index: 3
#2Yasunori Suematsu (Fukuoka University)H-Index: 10
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 5 authors...
Background: Endothelial dysfunction is an early phase of atherosclerosis and causes atherosclerotic cardiovascular disease (ASCVD), but the cutoff reactive hyperemia index (RHI) for identifying ASCVD patients under treatment for lifestyle diseases is unknown. Methods: Patients who visited Cardiology Section, Izumi General Medical Center, Kagoshima, Japan and were measured RHI using Endo-PAT 2000 during May 2014 and March 2016 were enrolled. We divided them into ASCVD and non-ASCVD groups and inv...
Source
#1Yuka Hirano (Fukuoka University)
#2Yasunori Suematsu (Fukuoka University)H-Index: 10
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 5 authors...
Abstract We report a case of a woman with primary hypertriglyceridemia caused by acquired glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 (GPIHBP1) autoantibody. This case highlights the necessity of detecting GPIHBP1 autoantibody in patients with acquired hypertriglyceridemia. (Level of Difficulty: Intermediate.)
Source
#1Yasunori Suematsu (Fukuoka University)H-Index: 10
#2Emi Kawachi (Fukuoka University)H-Index: 5
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 11 authors...
Abstract Background Apolipoprotein (Apo)A-I is a major protein component of high-density lipoprotein (HDL) that causes cholesterol efflux from peripheral cells through ATP-binding cassette transporter A1 (ABCA1) and the generation of HDL. Furthermore, it has a possible protective function against atherosclerotic cardiovascular disease (ASCVD). We previously developed a novel ApoA-I mimetic peptide without phospholipids (Fukuoka University ApoA-I Mimetic Peptide, FAMP). According to our previous ...
1 CitationsSource
#1Yoshino Matsuo (Fukuoka University)H-Index: 24
#2Yasunori Suematsu (Fukuoka University)H-Index: 10
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 7 authors...
ABSTRACTBACKGROUND: We hypothesized that the 5-oxo-1,2,4-oxadiazole moiety of azilsartan (AZL), which represents a small difference in the molecular structures of AZL and candesartan (CAN) [angiote...
Source
#1Kanako Tano (Fukuoka University)
#2Yasunori Suematsu (Fukuoka University)H-Index: 10
Last. Zenith Trial Investigators (Fukuoka University)
view all 8 authors...
Background: The combination of ezetimibe with statin therapy reduced cardiovascular events compared to statin monotherapy in IMPROVEIT study, and ezetimibe monotherapy attenuated atherosclerosis in basic study. We previously showed ezetimibe monotherapy was especially effective for metabolic syndrome (MetS) patients. We investigated the effects of ezetimibe monotherapy for high-density lipoprotein cholesterol (HDL-chol) function and platelet-activating factor acetylhydrolase (PAF-AH) activity. M...
Source
#1Yasunori Suematsu (UCI: University of California, Irvine)H-Index: 10
#2Masaki Goto (UCI: University of California, Irvine)H-Index: 1
Last. Hamid Moradi (UCI: University of California, Irvine)H-Index: 21
view all 13 authors...
Author(s): Suematsu, Yasunori; Goto, Masaki; Park, Christina; Nunes, Ane CF; Jing, WangHui; Streja, Elani; Rhee, Connie M; Cruz, Siobanth; Kashyap, Moti L; Vaziri, Nosratola D; Narayanaswami, Vasanthy; Kalantar-Zadeh, Kamyar; Moradi, Hamid | Abstract: CONTEXT:In end-stage renal disease (ESRD), serum high-density lipoprotein cholesterol (HDL-C) level is not an accurate predictor of mortality, partly because it does not necessarily correlate with indices of HDL function. Paraoxonase (PON) is a maj...
Source
#1Kanta Fujimi (Fukuoka University)H-Index: 6
#2Tomoki Imaizumi (Fukuoka University)
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 18 authors...
Abstract Background Cardiac rehabilitation (CR) is an essential component of care for patients with cardiovascular diseases (CVD). We aimed to evaluate clinical outcomes in outpatients with CVD who did and did not complete a 5-month CR program. Methods Three hundred thirty-two outpatients with CVD who participated in a 5-month CR program and were followed-up for maximum 5 years were registered. We divided the patients into two groups: those who completed the CR program (success group, n = 175) a...
Source
#1Yasunori Suematsu (Fukuoka University)H-Index: 10
#2Bo Zhang (Fukuoka University)H-Index: 27
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 12 authors...
Objectives The presence of a bystander witness is a crucial predictor of patient survival after out-of-hospital cardiac arrest (OHCA). However, the differences in survival and neurological outcomes among different types of citizen bystanders are not well understood. Design We analysed data from the All-Japan Utstein Registry, a prospective, nationwide, population-based, observational study that was started in January 2005. Setting The registry includes all patients with OHCA who were transported...
Source
#1Midori Miyazaki (Fukuoka University)H-Index: 1
#2Yasunori Suematsu (Fukuoka University)H-Index: 10
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 4 authors...
Background: Free fatty acid is a major energy source in the healthy heart and cluster of differentiation 36 (CD36) partially regulates the rate of myocardial fatty acid uptake. Here, we report a case of CD36 deficiency-related cardiomyopathy with a unique pathophysiology. Heart failure was accelerated by co-existing mitral valve prolapse (MVP) without a distinct phenotype of hypertrophic or dilated cardiomyopathy. Case summary: A middle-aged man was aware of dyspnoea and hospitalized for heart f...
Source
#1Yoshino Matsuo (Fukuoka University)H-Index: 24
#2Yasunori Suematsu (Fukuoka University)H-Index: 10
Last. Shin-ichiro Miura (Fukuoka University)H-Index: 34
view all 6 authors...
Abstract Blockers of G-protein coupled receptors (GPCRs), angiotensin II (Ang II) type 1 (AT1) receptor and β1-adrenergic (Ad) receptor, have been shown to improve the prognosis of cardiovascular disease. Cholesterol molecules in the cell membrane are needed to stabilize GPCRs as well as the cell membrane itself. We determined whether the functions of AT1 and β1-Ad receptors were changed by cholesterol depletion from cardiovascular cell membranes. Ang II-induced inositol phosphate production thr...
Source
1234567